Public Policy Resources

Share

As a recognized expert in cancer health policy, ACS CAN develops reports, white papers, testimony, fact sheets, regulatory comment letters and public policy on a wide range of issues related to preventing cancer and improving the health care system for persons with cancer and survivors.  We encourage you to use this resource to learn more about our issue priorities and policy work. If you can't find something you need, you may contact us by using our contact form and selecting Policy Resources from the drop-down menu.

Search for Resources

FILTER BY:

Woman seeing her physician

Access to Health Care

ACS CAN advocates for policies that provide access to treatments and services people with cancer need for their care - including those who may be newly diagnosed, in active treatment and cancer survivors.

This factsheet explains what health care tax credits (also known as "enhanced tax credits") are and why Congress needs to extend them before they expire at the end of the year.

ACS CAN filed a comment letter regarding the following policies included in the calendar year 2026 Medicare Physician Fee Schedule proposed rule:

Drug therapies are the bedrock of cancer care. Making these therapies affordable, while continuing to encourage innovation of new treatments, is crucial to accomplishing the mission of the American Cancer Society Cancer Action Network (ACS CAN) to end cancer as we know it, for everyone. ACS CAN has long fought for public policies that support both the affordability and availability of medically necessary prescription drugs. 
 

Photo of ACS CAN Volunteers at Advocacy Event to Support Cancer Research Funding

Research, Funding and Drug Development

Improvements in outcomes for cancer patients require continued research and innovation.  ACS CAN advocates for robust federal funding for cancer research, as well as research and drug approval policies that accelerate the development of new treatments while still ensuring patient safety.

Our latest survey finds 80% of cancer patients and survivors agree that industries making FDA-regulated products should provide some of the cost of FDA’s public health oversight. The survey also reveals hesitency toward the increased use of AI, mirroring the sentiment of the American public. Cancer patients and survivors offer tempered support for the use of AI in FDA product reviews if funding cuts extend review times, with a plurality undecided on whether they support or oppose it.

Over 130 organizations have endorsed the Clinical Trial Modernization Act (H.R. 3521).  The legislation would address known barriers to cancer clinical trial participation, enabling financial and technical support of patients enrolled on trials while protecting them from unexpected tax burdens from that support. 

The Clinical Trial Modernization Act (H.R. 3521) increase access to clinical trials by allowing clinical trial sponsors to provide financial support to patients for costs associated with their trial participation, including medical cost-sharing like copays, and non-medical expenses such as travel, parking, food and lodging.

Photo of Making Strides Against Breast Cancer Event Participant

Prevention and Early Detection

ACS CAN advocates for public policies that can prevent nearly half of all cancer deaths by ensuring access to recommended cancer screenings, protecting the public from skin cancer risk, reducing tobacco use and exposure to secondhand smoke and supporting people in increasing physical activity, eating a healthy diet, and managing their weight.

Young women in the U.S. are increasingly being diagnosed with breast cancer. About 16% of all new cases of breast
cancer in the U.S. are in women younger than 50. The impact on young women’s lives can be devastating, as breast

Access to preventive services saves lives. Over the past four decades, cancer prevention and screening services alone have averted approximately 4.75 million deaths from breast, cervical, colorectal, lung and prostate cancers.

Vaccinations are an essential part of care for people with cancer and their families. The American Cancer Society Cancer Action Network (ACS CAN) advocates for science-based policies that improve access to vaccines that prevent and treat cancer as well as protect people living with cancer.

Doctor and Patient

Health Equity

ACS CAN supports health equity efforts for all Americans so they may receive access to quality care, no matter their race, ethnicity, sexual orientation, income level or ZIP code. 

El cáncer de seno es el tipo de cáncer que se diagnostica con mayor frecuencia en mujeres en EE.UU. Aunque en lasúltimas décadas se han logrado avances sustanciales en la reducción de la mortalidad por esta enfermedad,persisten desigualdades, especialmente entre las mujeres de raza negra.

The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) along with partners appreciate the opportunity to comment on the Patient Navigation provisions of CY2025 Medicare Physician Fee Schedule.

The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) are united in the goal of achieving health equity and access to quality care across the cancer continuum through effective patient navigation. Yet to date, patient navigation services are still absen